Methyl 6-methylnicotinate (CAS 5470-70-2) is an important chemical entity that plays a pivotal role in drug discovery, with a specific emphasis on therapies for Central Nervous System (CNS) disorders. Its structural characteristics make it an invaluable intermediate in the synthesis of complex molecules designed to interact with specific biological targets.

In the realm of CNS drug discovery, Methyl 6-methylnicotinate is particularly noted for its use in creating inhibitors for enzymes like D-amino acid oxidase and D-aspartate oxidase. These enzymes are implicated in various neurological conditions, and developing effective inhibitors is a significant area of pharmaceutical research. The compound's reliable supply is essential for researchers working on these critical therapeutic advancements.

When seeking to purchase Methyl 6-methylnicotinate, pharmaceutical companies and research laboratories often look for suppliers who can guarantee consistent quality and purity. The price of Methyl 6-methylnicotinate can fluctuate based on market demand, production scale, and supplier. However, the strategic importance of this chemical in developing treatments for debilitating CNS disorders ensures its continued demand.

The synthesis of Methyl 6-methylnicotinate, while established, requires precise execution to yield a high-quality product suitable for pharmaceutical applications. Global manufacturers and suppliers, including those in China, provide this intermediate, facilitating drug development pipelines worldwide. For those in the pharmaceutical industry, understanding the applications and sourcing Methyl 6-methylnicotinate from reputable providers like NINGBO INNO PHARMCHEM CO.,LTD. is key to successful research and development efforts in CNS therapies.